Unichem Labs Q1 FY27: profit at Rs 41.47 cr versus loss, revenue up 20%
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 14.6 pts more than Nifty Microcap 250 and 14.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q1 FY27 (quarter ended 30 June 2026) saw Unichem Laboratories post consolidated revenue of Rs 632.62 cr, up 20% from Rs 526.60 cr a year ago. Net profit surged to Rs 41.47 cr from a loss of Rs 10.47 cr in Q1 FY26, with basic EPS of Rs 5.89. Standalone revenue dipped to Rs 366.27 cr from Rs 384.25 cr but turned to a profit of Rs 5.53 cr from a loss. Auditors N A Shah Associates gave an unmodified review report on both results. No exceptional items in this quarter.
Sharp turnaround to consolidated profit with 20 percent revenue growth and clean auditor report, likely to be viewed positively by markets.